We are live on ! Find out more
NUVB icon

Nuvation Bio
NUVB

127 hedge funds and large institutions have $267M invested in Nuvation Bio in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 32

33% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 18

5% more funds holding

Funds holding: 121 → 127 (+6)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.07% less ownership

Funds ownership: 65.26% → 64.19% (-1.1%)

16% less capital invested

Capital invested by funds: $318M → $267M (-$50.2M)

Holders
127
Holders Change
+6
Holders Change %
+4.96%
% of All Funds
2.04%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
49
Reduced
32
Closed
18
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$25K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$11.3M
2
BlackRock
BlackRock
New York
+$1.44M
3
Millennium Management
Millennium Management
New York
+$763K
4
HF
HRT Financial
New York
+$672K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$646K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$11.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.72M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.49M
4
DTC
Deep Track Capital
Connecticut
-$2.23M
5
FCM
Farallon Capital Management
California
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$981K -$130K -64,031 -11%
CC
27
Clearline Capital
New York
$949K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$901K +$58.3K +28,837 +7%
Morgan Stanley
29
Morgan Stanley
New York
$835K +$474K +234,120 +117%
HF
30
HRT Financial
New York
$637K +$672K +331,955 New
AA
31
AlphaCentric Advisors
Puerto Rico
$624K +$223K +110,000 +51%
Bank of America
32
Bank of America
North Carolina
$586K +$204K +100,738 +49%
Swiss National Bank
33
Swiss National Bank
Switzerland
$542K – – –
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$504K +$531K +262,616 New
AAA
35
Affinity Asset Advisors
New York
$480K +$506K +250,000 New
GCP
36
GSA Capital Partners
United Kingdom
$475K +$99.5K +49,164 +25%
Goldman Sachs
37
Goldman Sachs
New York
$463K -$613K -303,197 -56%
NM
38
Newtyn Management
New York
$461K +$60.7K +30,000 +14%
Ensign Peak Advisors
39
Ensign Peak Advisors
Utah
$453K +$21.7K +10,712 +5%
AG
40
Algert Global
California
$387K +$91.3K +45,110 +29%
IP
41
Intellectus Partners
California
$352K +$18.7K +9,223 +5%
RC
42
RBF Capital
California
$339K +$360K +177,760 New
AllianceBernstein
43
AllianceBernstein
Tennessee
$337K +$25.1K +12,400 +8%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$335K +$5.06K +2,499 +1%
Jane Street
45
Jane Street
New York
$303K +$1.69K +837 +0.5%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$288K +$3K +1,484 +1%
E
47
Ergoteles
New York
$282K +$298K +147,129 New
UBS AM
48
UBS AM
Illinois
$281K +$8.53K +4,216 +3%
Renaissance Technologies
49
Renaissance Technologies
New York
$277K -$235K -116,315 -45%
CAM
50
Cresset Asset Management
Illinois
$244K -$139K -68,900 -35%
1
2
3 4 5

NUVB Hedge Fund Activity: Q4 2022 in Review

127 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q4 2022, worth a combined $267M — down 16% from $318M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NUVB positions and 18 closed out — a net gain of 6 holders — while 49 added to existing stakes and 32 trimmed.

The largest buyer was Deerfield Management, adding an estimated $11.3M. The largest seller was Baupost Group, cutting an estimated $11.4M.

  • 127 institutional investors held Nuvation Bio (NUVB) as of Q4 2022, up from 121 in Q3 2022.
  • Funds reported $267M of Nuvation Bio stock for Q4 2022, down 16% quarter-over-quarter.
  • 24 funds opened new Nuvation Bio positions in Q4 2022 and 18 closed out, a net change of +6 holders.
  • The largest Nuvation Bio buyer in Q4 2022 was Deerfield Management, an estimated $11.3M added.
  • The largest Nuvation Bio seller in Q4 2022 was Baupost Group, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2022.